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Abstract: Human exposure to nanomaterials and nanoparticles is increasing rapidly, but their 
effects on human health are still largely unknown. Epigenetic modifications are attracting ever 
more interest as possible underlying molecular mechanisms of gene–environment interac-
tions, highlighting them as potential molecular targets following exposure to nanomaterials 
and nanoparticles. Interestingly, recent research has identified changes in DNA methylation, 
histone post-translational modifications, and noncoding RNAs in mammalian cells exposed to 
nanomaterials and nanoparticles. However, the challenge for the future will be to determine the 
molecular pathways driving these epigenetic alterations, the possible functional consequences, 
and the potential effects on health.
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Introduction
During the last decade, we have witnessed a tremendous increase in the use of 
nanoparticles and nanomaterials in several areas of human life, chemical industry, 
food technology, cosmetics and biomedicine, among others (Table 1).1,2 This rise 
in use is the consequence of developments in nanotechnology, defined according to 
the US Government’s National Nanotechnology Initiative as “the understanding and 
control of matter at dimensions of roughly 1 to 100 nm, where unique phenomena 
enable novel applications.”
Particle sizes up to 100 nm determine changes in the physical and chemical 
properties of materials compared to those observed at larger scales; for instance, 
chemical reactivity, electrical conductivity, melting point, fluorescence, and magnetism 
are all affected by size. This is mainly due to the increase in surface area of nanomateri-
als compared with larger-scale particles of similar masses, enabling increased contact 
with the surrounding materials and therefore changes in their reactivity. For example, 
titanium dioxide (TiO
2
) particles lose their white color and become colorless at sizes 
below 50 nm. Other types of particles considered to have electrical insulation proper-
ties may become conductive at the nanosize, and substances with low solubility can 
become more soluble at sizes below 100 nm.3 Furthermore, nanoparticles can combine 
(homogeneously or heterogeneously) as aggregates or agglomerates; aggregates are 
formed by particles strongly linked by molecular-type bonds, while agglomerates 
are formed by particles interlinked by van der Waals-type lower energy bonds.4
Also related to the size of nanoparticles is their coefficient of diffusion, which is 
inversely proportional to their size and ensures that their main transport mechanism in 
the environment is air diffusion.4 As a result, independent of their current use in human 
endeavors, the effects of human exposure to nanoparticles have attracted interest in the 
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last few years from a safety/health point of view. Since it has 
recently became obvious that the misregulation of cellular 
epigenetic mechanisms may be detrimental to health, this has 
further fueled interest in the study of the effects of nanopar-
ticle exposure on epigenetic regulation.5 While epigenetic 
modifications can be very stable and, in some cases, passed 
on to multiple generations, they can also change dynamically 
in response to specific cellular conditions or environmental 
stimuli. The effect of the environment on the epigenome has 
been extensively reviewed.6,7 Some authors have already 
emphasized that the potential epigenetic properties of nano-
materials could not only affect the exposed individuals but 
also their offspring.8
Here, we will focus on the potential effect of exposure 
to nanoparticles and nanomaterials on the epigenome, 
considering epigenetic regulation as the biological mecha-
nism whereby DNA, RNA, and proteins are chemically 
or structurally modified without changing their primary 
sequence. These epigenetic modifications play critical roles 
in the regulation of numerous cellular processes, including 
gene expression and DNA replication and recombination. 
Epigenetic regulatory mechanisms include, among others, 
DNA methylation and hydroxymethylation, histone modifi-
cation, chromatin remodeling, RNA methylation, and small 
and long noncoding RNAs (ncRNAs).
There are many different types of nanoparticles and nano-
materials that are available with completely different physical 
and chemical properties; although there is a natural tendency 
to assess the physiological effects of nanosubstances in gen-
eral, in reality, their impact on the organism will be highly 
dependent on the substance in question. Furthermore, some 
authors remark that unintentionally emitted nanoparticles in 
natural systems can be dynamically affected by the environ-
ment, complicating even further the assessment of their effect 
on exposed populations.9
DNA methylation changes 
in response to exposure to 
nanoparticles and nanomaterials
DNA methylation consists in the covalent chemical modi-
fication of cytosines at the C5 position with a methyl group 
and occurs at CpG dinucleotides, which are clustered into 
CpG islands, which affects DNA accessibility to the cel-
lular transcriptional machinery and typically turns off gene 
expression. This methylation process is catalyzed by DNA 
methyltransferases (DNMT3a/DNMT3b and DNMT1).10 
Demethylation, in contrast, can occur either passively or 
through active mechanisms in which 10–11 translocator 
proteins, 5-hydroxymethylcytosine formation, and thymidine 
glycosidases are all implicated.11
A rapid increase in the use of nanocomposites in the last 
decade has led several research groups to study alterations in 
DNA methylation patterns in response to these substances. 
Examples of nanosubstances studied include carbon-based 
nanoparticles,12 nano-hydroxyapatite,13 nanoparticles of 
TiO
2
 and copper oxides (CuO),14,15 and SiO
2
.16,17 In general, 
these studies have identified a number of both locus-specific 
and global DNA methylation changes in response to nano-
particle and nanomaterial exposure. However, these works 
provide neither genome-wide data nor correlation with gene 
expression, which makes it difficult to interpret the extent 
of DNA methylation changes and their possible functional 
effects. To our knowledge, the first report on the effect of 
a nanosized substance on DNA methylation was published 
only six years ago.16 In this study, the authors incubated the 
human epidermal keratinocyte cell line HaCaT with increas-
ing concentrations of 15 nm SiO
2
 for 24 h and then analyzed 
the global DNA methylation changes using high-performance 
capillary electrophoresis and immunofluorescence staining. 
Both assays showed a relative decrease of more than 20% 
in global DNA methylation. SiO
2
 was also associated with 
a decrease in maintenance and de novo DNMTs, leading the 
authors to propose that deregulation of DNMTs might play 
an important role in the process. However, such a strong 
effect in such short period of time could also imply active 
demethylation processes. Global DNA hypomethylation in 
response to nanosized substances was also recently observed 
in vivo.12 In this study, the authors detected significant DNA 
hypomethylation in the lungs and blood of mice exposed by 
airways to a type of multiwall carbon nanotubes (MWCN). 
In contrast to the findings of Gong et al16 with regard to 
very early DNA methylation changes, the effects were 
observed only after seven days of exposure in this study.12 
Complicating the scenario even further, a recent study using 
high-performance liquid chromatography-mass spectrometry 
(HPLC-MS) found an increase in global methylation in a 
human lung cancer cell line exposed to different concentra-
tions of carbon-based nanoparticles, but a reduction in the 
expression of DNMTs to different extents depending on the 
type of carbon nanoparticle.18 Therefore, it is clear that future 
research is still needed to determine the effect of nanoparticle 
size and type and the effect of in vivo conditions on the time 
of exposure required to induce DNA methylation changes.
Global DNA methylation mainly depends on the methy-
lation level of repeated DNA where the majority of the 
cytosine methylation occurs in the genome, and that is why 
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the level of DNA methylation at certain repeats is widely 
accepted as a surrogate of global DNA methylation.19 This 
is of considerable relevance in this context because some 
recent studies have found a substantial decrease in repeated 
DNA methylation in response to ambient-air microparticu-
lates exposure.20,21 In contrast, the effect of different types 
of nanoparticles on the methylome of cultured mammalian 
cells is less clear. Indeed, a recent study that analyzed the 
DNA methylation changes at LINE1 and Alu repeats in mam-
malian cells exposed to different concentrations of printer-
emitted engineered nanoparticles and nanoparticles of mild 
steel welding fumes, CuO, and TiO
2
 found both hyper- and 
hypomethylation, depending on the cell type and the repeated 
DNA sequence involved.14,15 Interestingly, although the DNA 
methylation changes were small, nanoparticle exposure was 
clearly associated with DNMT downregulation and repeated 
DNA reactivation. It is also worth noting that experiments 
using mouse models have revealed similar methylation 
changes in response to nanoparticle exposure.22,23 These 
results highlight the fact that the functional consequences of 
nanoparticle-dependent DNA methylation changes are still 
largely unknown and that other molecular mechanisms must 
be involved in the upregulation of repeated DNA.
In addition to the methylation changes at the global 
and repeated DNA level, some studies have identified the 
changes in response to nanoparticle exposure at specific loci. 
It should be noted that, generally, promoter hypermethyla-
tion is associated with gene silencing, whereas the effect of 
intragenic methylation is not so clear, although it might also 
have a role in regulating gene expression.24 A recent work 
by Ha et al13 reported a 40% increase in DNA methylation 
at the promoter region of the osteoblast lineage commitment 
gene alkaline phosphatase (ALPL) in murine bone marrow 
stromal cells, following treatment with nano-hydroxyapatite, 
a compound being studied as a therapeutic biomaterial for 
use as a functional scaffold and implant coating for skeletal 
repair and dental applications.25,26 An association was found 
between nano-hydroxyapatite-dependent promoter hyper-
methylation and ALPL gene repression and, consequently, 
osteoblast differentiation, which could have important health 
implications (Figure 1). Although these results are interest-
ing, future research analyzing single CpG methylation at 
different regions of the ALPL gene is needed to determine 
the precise role of nanoparticle-dependent DNA methylation 
changes in gene expression and to determine the molecular 
mechanism through which nano-hydroxyapatite induces 
hypermethylation.
In the same vein, promoter-specific hypermethylation of 
the poly (ADP-ribose) polymerase 1 (PARP-1) was recently 
reported upon exposure of human lung adenocarcinoma cells 
to TiO
2
 nanoparticles.27 PARP-1 is a DNA-binding protein 
involved in DNA repair, proliferation, and chromatin modifi-
cation, among other cellular processes. PARP-1 has also been 
found to form a complex with the DNA methyltransferase 
DNMT1, the histone H3K9 methyltransferase G9a, and the 
histone ubiquitin ligase Np95, indicative of a link between 
polyADP-ribosylation and the epigenome28 and suggesting 
that it contributes to the genome integrity.29 Treatment with 
SiO
2 
nanoparticles has also been found to induce the aber-
rant hypermethylation and inactivation of PARP-1 in human 
keratinocytes. Interestingly, DNMT1 knockdown restored 
PARP-1 promoter methylation levels and its expression,17 
further supporting the notion that epigenetic regulations could 
be involved in the response to SiO
2 
nanoparticle exposure.
Nanosized substances do not always induce DNA hyper-
methylation at single-copy sequences. For example, using 
Figure 1 Possible DNA methylation alteration in response to nano-hydroxyapatite (nano-HAp) exposure in osteoblasts. exposure of early stage differentiating osteoblasts 
to nano-Hap might induce, through a still unknown molecular mechanism, alkaline phosphatase (ALPL) promoter hypermethylation and gene repression, which in turn could 
alter lineage commitment and differentiation of bone-forming osteoblasts.
Abbreviations: C, cytosine; mC, methylcytosine; e1, exon 1; e2, exon 2.
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bisulfite pyrosequencing, Brown et al recently showed a 
decrease in the promoter methylation levels of the INF-γ 
and TNF-α genes in the lungs of mice exposed by airways 
to MWCN.12 In the case of the TNF-α gene, there was a 
negative correlation between DNA methylation and gene 
expression, which suggests that DNA methylation might play 
a role in the regulation of this gene in response to MWCN 
and, in consequence, in the regulation of the inflammatory 
response following MWCNT exposure. In another study, 
researchers identified hypo- and hypermethylation of the 
differentially methylated regions of the imprinted genes 
Zac1 and Igf2r, respectively, in mice embryos exposed to 
silver nanoparticles.30 These alterations might have important 
implications in disease development, since DNA methylation 
plays a critical role in the regulation of gene imprinting,31 a 
critical molecular process during embryonic development. 
Future research is needed to determine the possible functional 
consequences of these alterations during embryo develop-
ment. Silver nanoparticles have also been shown to alter 
DNA methylation in mouse hippocampus neuronal cells,32 
thus suggesting that this type of nanoparticle is an ontogenic-
independent modulator of the epigenome.
Therefore, at this moment, it seems clear that, in general, 
nanoparticle exposure can induce loss of DNA methylation. 
But, to our knowledge, there are no reports on DNA methyla-
tion levels in human populations exposed to specific types 
of nanoparticles, although there are reports on methylome 
changes after exposure to ambient-air pollution, where 
particulate matter (PM) is included at the nano- and micro-
scales. A recent study found that exposure to air pollutants 
(in this case, microparticles of NO
2
, PM
10
, PM
2.5
, and O
3
) 
in healthy human individuals led to a small but statistically 
significant decrease in global DNA methylation.33 However, 
another study found increased or decreased methylation 
levels of ten different repeated DNA sequences in men 
exposed to airborne pollutant.34 The authors attributed this 
variability in response to the differences in susceptibility of 
DNMTs to environmental factors, which could modify their 
methylation activity on specific DNA repeated sequences. 
Of note is also a recent paper reporting the lack of associa-
tion between global DNA and ambient PM in dogs.35 The 
reason for these differences is not clear and, in consequence, 
further research is needed to establish the factors determin-
ing the effect of microparticulates on methylome in vivo. 
Moreover, considering that most studies have been carried 
out on peripheral blood and that DNA methylation patterns 
are in fact cell-type specific, changes in blood cell composi-
tion in response to exposure to airborne pollutants could be 
a confounding factor, and should thus be taken into account 
in future studies.
Effect of nanomaterials and 
nanoparticles on histone post-
translational modifications
DNA packaging strength is dependent on other epigenetic 
marks collectively known as histone modifications. There are 
a variety of such chemical marks (eg, acetylation, methyla-
tion, phosphorylation), all of which modify the terminal 
amino tails of histones, changing how tightly or loosely the 
DNA is packaged. In general, when the wrapping is tight, a 
gene is less accessible to the cellular transcription machinery 
and is consequently expressed less, and when the wrapping 
is lost, the gene generally becomes more accessible.
The entry of nanoparticles into the cell nucleus can 
modulate different cellular functions depending on the chro-
matin region affected; while nanoparticle-mediated hetero-
chromatin changes cause marked shrinkage of the nucleus, 
euchromatin is only marginally modified.36
The effect of nanosized substances on histone post-
translational modifications has been studied much less than 
their effect on DNA methylation. However, some preliminary 
studies suggest that histone modifications are also important 
molecular targets for different types of nanoparticles. For 
example, a recent study found that the nucleus of human 
breast cancer cells undergoes chromatin condensation and 
global histone hypoacetylation after quantum dot treatment 
with cadmium telluride,37 a nanosubstance currently being 
considered as a potential diagnostic, therapeutic, and imag-
ing tool. Incubation of MCF-7 cells with cadmium telluride 
quantum dot for either 4 h or 24 h resulted in global histone 
H3 hypoacetylation and reduced gene transcription in both 
cases. Intriguingly, quantum dot treatment increased the 
expression of some apoptotic genes through the activation 
of p53. However, the effect of quantum dot exposure on 
cell death was not investigated in this study. Future research 
should determine the possible effects of specific nanoparticles 
on cancer cell death.
Silver nanoparticles have also been recently proposed 
to affect histone post-translational modifications. These 
compounds are being utilized in an increasing number of 
fields and can be found as components of antibacterial coat-
ings, antistatic materials, superconductors, and biosensors. 
The potential of silver nanoparticles to penetrate inside the 
nucleus is reported to affect various enzymes involved in 
chromatin remodeling, such as histone deacetylases.38 In this 
regard, a recent study showed that sublethal concentrations 
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of silver nanoparticles induced a reduction in hemoglobin 
levels in mouse erythroleukemia cells, possibly through the 
diminished methylation of H3K4me3 and H3K79me1.39 
Although the underlying molecular mechanisms are not 
known, the latter authors presented data suggesting that the 
effect could be mediated by the inhibition of specific histone 
methyltransferases or even through the binding of silver 
nanoparticles to histones H3 and H4 (Figure 2).
The shape, or more precisely the topography, of micro- 
and nanomaterials used as scaffolds for biological and 
medical applications seems to affect the cellular epigenome, 
specifically through histone modification alterations. Further-
more, reprogramming somatic cells as pluripotent stem cells 
is more efficient when bioengineered substrates are used.40 
Supporting this notion, a recent study showed that the topog-
raphy of the cell substrate can modulate cell differentiation 
and reprogramming.41 Through as yet unknown molecular 
mechanisms, microgrooved surfaces lead to increased histone 
H3 acetylation and methylation which is assumed to play an 
important role in the regulation of cell differentiation and 
reprogramming processes.41
effect of exposure to nanoparticles on 
ncRNA expression
The ncRNAs represent another important component of 
the epigenetic machinery. They can be classified as short 
ncRNAs (with less than 200 nucleotides) and long ncRNAs 
(include all larger transcripts). Furthermore, there are sev-
eral subtypes of both short (eg, miRNAs, endo-siRNAs, or 
piRNAs) and long ncRNAs (eg, natural antisense transcripts, 
long intergenic noncoding RNAs, or sense intronic). Many 
ncRNAs irrespective of their nature or length are able to 
modulate gene expression through their interaction with other 
epigenetic processes, mainly with the expression and func-
tion of proteins involved in histone modifications, chromatin 
remodeling, and/or DNA methylation.42,43 Therefore, many 
ncRNAs are targets of these same processes.43 It is the plas-
ticity of ncRNAs and their capacity for dynamic interaction 
with DNA, RNA, and proteins which confers on them the 
ability to mediate in the various epigenetic processes through 
which cells respond to diverse external or internal stimuli.42 
It is therefore not unexpected that, as with DNA methyla-
tion and histone post-translational modification, the biology 
of ncRNAs can also be affected by exposure to nanosized 
substances.44 The study by Halappanavar et al was one of 
the first studies evidencing the effect of nanocompounds 
on the expression of ncRNAs.45 Using a mouse model, they 
identified significant changes in the expression of 16 miRNAs 
in lungs of mice exposed to surface-coated nanotitanium 
dioxide particles (nanoTiO
2
), among which mmu-miR-449a 
presented the greatest change compared with controls. The 
same study also showed that nanoTiO
2
 also induced lung 
inflammation, although the data could not establish a direct 
link between miRNA alteration and lung injury (Figure 3). 
Furthermore, a later study from a different group found that 
pulmonary instillations of Printex® 90, a type of carbon 
black nanoparticle, resulted in a sustained and substantial 
induction of three miRNAs in mice for up to one month after 
exposure. Interestingly, the affected miRNAs identified in 
each study were different, which raises important questions 
in relation to the possibility of different nanoparticles target-
ing specific miRNAs.
In addition to the lungs, nanosized compounds can also 
affect miRNA expression in other organs in mice. In this 
Figure 2 Model explaining the possible molecular mechanisms underlying the effect of Ag-nanoparticles on the regulation of the β-globin gene in mouse erythroleukemia 
cells. exposure to Ag-nanoparticles induces β-globin repression through still not fully understood molecular mechanisms that might involve inhibition of specific histone 
methyl transferases and direct binding of the nanoparticles to histones.
Abbreviations: Me, methylation; H3, histone H3; HMTs, histone methyltransferases; Ag, silver.
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regard, a study by Nagano et al identified changes in the 
blood levels of three liver-specific miRNAs in adult mice 
exposed to70 nm diameter silica nanoparticles.46 They found 
that the sensitivity of one of the miRNAs for liver damage 
was similar to other well-known markers of liver damage. 
As they can be detected in blood, the authors suggest that 
altered liver-specific miRNA levels might represent a novel 
noninvasive biomarker of liver damage in response to nano-
particle exposure. In mice, it has even been proposed that 
nanoparticle exposure has transplacental epigenetic effects. 
In their study, Balansky et al found that treatment of pregnant 
mice with gold nanoparticles (average size of 40–100 nm) 
induced changes in the expression of 28 miRNAs in fetal 
tissues.47 As the direct physiological consequences were not 
assessed, further research is needed to more fully determine 
the role of nanoparticles in epigenetic regulation during 
embryonic development, a time period in which epigenetic 
regulation plays a critical role in processes such us cell fate 
determination and cell differentiation, among others.48
Till date, the effect of nanoparticle exposure on miRNA 
expression in humans has only been assessed in vitro. A study 
by Eom et al showed that exposure of Jurkat T cells to silver 
nanoparticles altered the expression of 63 miRNAs.49 In line 
with this effect in vitro, incubation of NIH/3T murine fibro-
blasts with CdTe quantum dots has been shown to induce 
significant expression changes in 51 miRNAs.50 In addition, 
changes in miRNAs, together with chromatin condensation 
and reorganization, have been reported upon treatment of 
lung fibroblasts with gold nanoparticles.51 Taken together, 
the current data suggest that nanomaterial exposure induces 
alterations in miRNA expression both in vivo and in vitro. 
However, the underlying molecular mechanisms remain 
largely unknown.
Conclusion
The rise in the use of nanoparticles in the last decade prob-
ably only represents the tip of the iceberg in terms of what 
the future holds. Given the vast array of fields in which 
nanoparticles are being used and studied (Table 1), human 
exposure can only be expected to grow. The epigenetic 
effects of this exposure are beginning to be studied, but a 
great deal of work still needs to be done to reveal the whole 
picture of the impact of such exposure, not only from the 
epigenetic point of view, where broader epigenomic and 
mechanistic data are lacking, but also in terms of concrete 
data on the properties of nanoparticles, composition, size, 
charge, and functionalization, and whether or not they are 
degradable or modifiable by external/ambient conditions 
(Figure 4). Another important challenge for the future will 
be to determine the possible effect of the genetic variability 
on the susceptibility to specific nanoparticle exposure.
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Figure 3 Titanium dioxide nanoparticles (nanoTiO2) have been shown to induce 
pulmonary inflammation. Although the underlying molecular mechanisms are still 
poorly understood, changes in gene and miRNA expression might play an important 
role in the process.
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Figure 4 Potential factors affecting nanoparticle exposure-associated epigenetic 
alterations include, among others, the type and physicochemical characteristics of 
the nanoparticle, the type of tissue, and interindividual genetic variation. Human 
exposure to nanoparticles is expected to increase in the coming years. The epigenetic 
effects of this exposure are beginning to be studied, but a great deal of work still 
needs to be done to reveal the whole picture of the impact of such exposure, not 
only from the epigenetic point of view, where broader epigenomic and mechanistic 
data are lacking, but also in terms of concrete data on the properties of specific 
nanoparticles.
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